EUVIMEDEUVIMED entdecken
Crossref

Design of Novel Antidiabetic Agents Using 3D‐QSAR, Molecular Docking, ADMET Analysis, Molecular Dynamics, Ligand Transport, and Retrosynthesis

Lhoucine Naanaai, Mohamed Ouabane, Said El Rhabori, Youness Moukhliss, Abdellah El Aissouq, Abdelkrim Guendouzi, Hicham Zaitan, Mohammed Bouachrine, Fouad Khalil

ChemistrySelect · 2025-10 · 10 (38)

DOI: 10.1002/slct.202502280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 07.10.2025. Verfasst von Lhoucine Naanaai und 8 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

α‐Glycosidase enzymes are central to the digestion of carbohydrates, which directly affects diabetes mellitus (DM), especially Type 2 diabetes. Molecular docking, molecular dynamics, ligand transport, 3D‐QSAR modeling, pharmacokinetic properties (ADMET), and retrosynthesis were all combined in this computational analysis to find new ligands derived from Indenoquinoxaline‐phenylacrylohydrazide hybrids as α‐glucosidase inhibitors. PLS and comparative molecular similarity index analysis (CoMSIA) were used to generate the best 3D‐QSAR model, which showed good predictive and correlative abilities (Q 2 = 0.652, R 2 = 0.954, and SEE = 0.130). The designed ligands interacted in the enzyme pocket (5ZCC) with several interactions, depending on molecular docking. In addition, molecular dynamics simulations were then used to verify the stability of these ligands over time in the protein's active site. The CaverDock program was implemented to track the movement of designed ligands from the protein's active site to its surface, and also to calculate the biological efficacy of these compounds. In order to demonstrate the various synthesis pathways of the most active molecule, retrosynthesis was finally employed. The findings indicate that because of its capacity to inhibit the α‐glucosidase enzyme, this compound has emerged as the most promising drug candidate for experimental testing both in vitro and in vivo.

Zitieren

APA

Naanaai, L., Ouabane, M., Rhabori, S. E., Moukhliss, Y., Aissouq, A. E., Guendouzi, A., Zaitan, H., Bouachrine, M., & Khalil, F. (2025). Design of Novel Antidiabetic Agents Using 3D‐QSAR, Molecular Docking, ADMET Analysis, Molecular Dynamics, Ligand Transport, and Retrosynthesis. ChemistrySelect, 10(38). https://doi.org/10.1002/slct.202502280

Vancouver

Naanaai L, Ouabane M, Rhabori SE, Moukhliss Y, Aissouq AE, Guendouzi A, et al. Design of Novel Antidiabetic Agents Using 3D‐QSAR, Molecular Docking, ADMET Analysis, Molecular Dynamics, Ligand Transport, and Retrosynthesis. ChemistrySelect. 2025;10(38). doi:10.1002/slct.202502280

BibTeX
@article{Naanaai2025,
  author = {Naanaai, Lhoucine and Ouabane, Mohamed and Rhabori, Said El and Moukhliss, Youness and Aissouq, Abdellah El and Guendouzi, Abdelkrim and Zaitan, Hicham and Bouachrine, Mohammed and Khalil, Fouad},
  title = {Design of Novel Antidiabetic Agents Using 3D‐QSAR, Molecular Docking, ADMET Analysis, Molecular Dynamics, Ligand Transport, and Retrosynthesis},
  journal = {ChemistrySelect},
  year = {2025},
  volume = {10},
  number = {38},
  doi = {10.1002/slct.202502280}
}
Kostenlos starten →